These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33885243)

  • 1. Radiological evaluation of ex novo high grade glioma: velocity of diametric expansion and acceleration time study.
    Altieri R; Certo F; Rocca G; Melcarne A; Garbossa D; Bianchi A; Crimi S; Pluchino A; Peschillo S; Barbagallo GMV
    Radiol Oncol; 2020 Dec; 55(1):26-34. PubMed ID: 33885243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of de novo high grade glioma: first description of growth parabola.
    Altieri R; Hirono S; Duffau H; Ducati A; Fontanella MM; La Rocca G; Melcarne A; Panciani PP; Spena G; Garbossa D
    J Neurosurg Sci; 2020 Aug; 64(4):399-403. PubMed ID: 28748908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of preoperative FLAIR MRI and ependymal proximity of tumor enhancement as surrogate markers of brain tumor origin.
    Smith TR; Hulou MM; Abecassis J; Das S; Chandler JP
    J Clin Neurosci; 2015 Sep; 22(9):1397-402. PubMed ID: 26055954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subventricular zone predicts high velocity of tumor expansion and poor clinical outcome in patients with low grade astrocytoma.
    Wen B; Fu F; Hu L; Cai Q; Xie J
    Clin Neurol Neurosurg; 2018 May; 168():12-17. PubMed ID: 29500965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
    J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
    Durmo F; Rydhög A; Testud F; Lätt J; Schmitt B; Rydelius A; Englund E; Bengzon J; van Zijl P; Knutsson L; Sundgren PC
    PLoS One; 2020; 15(12):e0244003. PubMed ID: 33373375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
    Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
    Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiology reporting of low-grade glioma growth underestimates tumor expansion.
    Gui C; Lau JC; Kosteniuk SE; Lee DH; Megyesi JF
    Acta Neurochir (Wien); 2019 Mar; 161(3):569-576. PubMed ID: 30756242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Value of Intraoperative and Early Postoperative Magnetic Resonance Imaging in Low-Grade Glioma Surgery: A Retrospective Study.
    Pala A; Brand C; Kapapa T; Hlavac M; König R; Schmitz B; Wirtz CR; Coburger J
    World Neurosurg; 2016 Sep; 93():191-7. PubMed ID: 27288582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data.
    Zetterling M; Roodakker KR; Berntsson SG; Edqvist PH; Latini F; Landtblom AM; Pontén F; Alafuzoff I; Larsson EM; Smits A
    J Neurosurg; 2016 Nov; 125(5):1155-1166. PubMed ID: 26918468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high
    Isal S; Gauchotte G; Rech F; Blonski M; Planel S; Chawki MB; Karcher G; Marie PY; Taillandier L; Verger A
    Br J Radiol; 2018 Apr; 91(1084):20170803. PubMed ID: 29271237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status.
    Grabner G; Kiesel B; Wöhrer A; Millesi M; Wurzer A; Göd S; Mallouhi A; Knosp E; Marosi C; Trattnig S; Wolfsberger S; Preusser M; Widhalm G
    Eur Radiol; 2017 Apr; 27(4):1556-1567. PubMed ID: 27300198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of central lymphoma and high-grade glioma: dynamic contrast-enhanced histogram.
    Zhang HW; Lyu GW; He WJ; Lei Y; Lin F; Feng YN; Wang MZ
    Acta Radiol; 2020 Sep; 61(9):1221-1227. PubMed ID: 31902220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of
    Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of texture analysis on MRI in grading cerebral gliomas.
    Skogen K; Schulz A; Dormagen JB; Ganeshan B; Helseth E; Server A
    Eur J Radiol; 2016 Apr; 85(4):824-9. PubMed ID: 26971430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
    Maynard J; Okuchi S; Wastling S; Busaidi AA; Almossawi O; Mbatha W; Brandner S; Jaunmuktane Z; Koc AM; Mancini L; Jäger R; Thust S
    Radiology; 2020 Jul; 296(1):111-121. PubMed ID: 32315266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACTC1 as an invasion and prognosis marker in glioma.
    Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
    J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.